FDA.reportPublic FDA data

risedronate sodium 150 MG Oral Tablet

RxCUI
905028
RxNorm name
risedronate sodium 150 MG Oral Tablet
Display name
risedronate sodium 150 MG Oral Tablet
Full name
risedronate sodium 150 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Risedronate SodiumRISEDRONATE SODIUMApotex Corp.b90f2e5b-10b8-29a7-0360-31bd0dae0ec22026-03-02Warnings, Adverse reactionsExact identifier
rxcui: 905028
risedronate sodiumRISEDRONATE SODIUMSun Pharmaceutical Industries, Inc.e0b5f0ed-ff40-4f0d-bb86-81a7ace9f3392026-02-17Warnings, Adverse reactionsExact identifier
rxcui: 905028
Risedronate SodiumRISEDRONATE SODIUMMylan Pharmaceuticals, Inc.f715718a-407d-4e2a-9834-74a8f1361d032026-02-12Warnings, Adverse reactionsExact identifier
rxcui: 905028
Risedronate SodiumRISEDRONATE SODIUMAurobindo Pharma Limiteda42a35e6-3e08-4b4f-ae56-47d4aec2322a2026-02-10Warnings, Adverse reactionsExact identifier
rxcui: 905028
ActonelRISEDRONATE SODIUMAllergan, Inc.24ed00e0-25e2-49a8-97fc-66c1b417dc0b2026-02-04Warnings, Adverse reactionsExact identifier
rxcui: 905028

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
24ed00e0-25e2-49a8-97fc-66c1b417dc0brisedronate sodium 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [SCD]231These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® ( risedronate sodium ) tablets , for oral use Initial U.S. Approval: 199 820260204
e0b5f0ed-ff40-4f0d-bb86-81a7ace9f339risedronate sodium 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [SCD]217These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260217
b90f2e5b-10b8-29a7-0360-31bd0dae0ec2risedronate sodium 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [SCD]215These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS, USP safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS, USP. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260302
f715718a-407d-4e2a-9834-74a8f1361d03risedronate sodium 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [SCD]213These highlights do not include all the information needed to use Risedronate Sodium safely and effectively. See full prescribing information for Risedronate Sodium . Risedronate Sodium tablets , for oral use Initial U.S. Approval: 199820260212
a42a35e6-3e08-4b4f-ae56-47d4aec2322arisedronate sodium 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [SCD]28These highlights do not include all the information needed to use RISEDRONATE SODIUM TABLETS safely and effectively. See Full Prescribing Information for RISEDRONATE SODIUM TABLETS. RISEDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 199820260210
4423d70a-b120-4653-bcf3-0c5ea8b97b0erisedronate sodium 150 MG Oral Tablet [PSN] · risedronate sodium 150 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® (risedronate sodium) tablets Initial U.S. Approval: 199820100324